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 Spectroscopic and inclusion properties of G-series chemical warfare 
agents and their simulants: A DFT study 
A computational protocol to predict the infrared spectra of chemical warfare 
agents (CWAs) tabun (GA), sarin (GB), soman (GD) and cyclosarin (GF) has 
been developed. Sarin was used to benchmark the method through gas phase 
simulations. DFT calculations using the EDF2 functional and diffuse 6-
311++G** basis set was found to give the closest match to experimental infrared 
spectra. Using the same functional the 6-31G (2df, 2p) basis set was found to be 
superior when hydrated sarin was modelled. GA, GB, GD and GF, together with 
11 commonly used simulants, were modelled in the gas and hydrated states. 
Complexes of GB and a number of CWA mimics with α-cyclodextrin were 
modelled to give insight into their different modes of inclusion. 
Keywords: density functional theory, chemical warfare agents, cyclodextrin, 
infrared spectra, inclusion complex 
 
Introduction 
The history of the development and use of Chemical Warfare Agents (CWAs) 
through, predominantly, the early and mid-twentieth century is well documented, 
and in 1993 the Chemical Weapons Convention banned the manufacture of such 
materials (1). Nevertheless, they have gained prominent attention over recent 
decades due to evidence of their use in Iraq in 1987 (2), Japan in 1994 (3) and 
1995 (4), and Syria in 2013 (5). In the event of deliberate or accidental release of 
CWAs it is essential to detect and destroy these highly toxic materials. A large 
number of hydrolytic, enzymatic and thermal destruction/degradation methods 
have been proposed (6-8) as have detection systems based on spectroscopic or 
spectrometric approaches (9, 10). However, recent interest in the supramolecular 
chemistry of CWAs has led to a significant number of reports exploring the 
molecular recognition properties of these molecules by functional materials. Such 
materials can act as sensors, destructive catalysts and responsive gels (11-15). 
Chemical agent simulants, with related structural or physical properties but with 
much lower toxicity than the CWAs, are often used by research groups interested 
in developing novel detection technologies or functional materials that may find 
 application in future protection or decontamination systems. Increased reliance on 
the use of simulants to develop promising technologies requires an improved 
understanding of how the properties of CWA and simulants correlate.  
 
Figure 1. Chemical warfare agents and simulants 
 
Key to developing novel methods of sensing and destroying CWAs through the 
formation of inclusion complexes is the ability of researchers to test prospective 
methods on simulants with the knowledge that they accurately reflect the 
physicochemical behaviour of CWAs most relevant to the task. Alternatively, there 
should be a clear understanding of how simulant data could be more effectively 
extrapolated to predict CWA behaviour; rare examples of CWA-simulant comparisons 
include the coordination of such molecules to lanthanides (11, 12), and the triggering of 
stimuli-responsive gels (15).  
  To more closely match the molecular properties of simulants to CWAs it is 
essential that the salient features of each CWA are also present in its selected simulant. 
At the most basic level these will include molecular structure and geometry. Reactivity 
of the phosphorus bonds, together with the chirality of the phosphorus atom, underlies 
the toxicity of CWAs. Whilst this reactivity should not be reproduced in a simulant, 
having similar vibrational modes should make it interact with sensors or decontaminants 
in a similar way. For example, if simulant and CWA P=O groups have similar 
vibrational frequencies then their ideal P-O bond lengths, electronic polarisation and 
predilection to interact with hydrogen bond donors will be almost identical. 
Consequently, when subjected to the same environment, such as inclusion within 
macrocycles or binding to imprinted polymers, simulants will give the same response as 
the CWA. The first step is therefore to develop a computational protocol that accurately 
predicts the geometries and vibrational modes of both CWAs and simulants. Once this 
has been achieved, the same approach can be used to investigate the reasons for the 
differences between CWA and simulant binding to substrates. Thus, these models can 
be used to predict the inclusion complexes which CWAs can form and, ideally, predict 
which simulants will form similar complexes. From this it will be possible to use 
appropriate simulants in place of CWAs with assurance that their inclusion behaviour 
will be similar when binding to receptors that form part of a sensor.  
Simple calculations to determine the gas phase structures of CWAs and 
simulants have been reported since 1985 when Ewig and Van Wazer modelled the ab 
initio structure of O-methyl methylphosphonofluoridate with the STO-3G and 321-G* 
basis sets (16). Subsequent work focused on either calculation of microwave spectra 
(17-19), of use when designing microwave-based sensors to detect CWAs, or surface 
interactions relevant to remediation or transport through porous materials (20-27). 
 Computer simulations generally consider gas phase structures. While these are of 
interest, particularly for sensor applications, it is also important to understand what 
occurs in aqueous solution, as investigated by the groups of Ault and Neimark, because 
atmospheric moisture is likely to affect detection (28-30).  
There has been limited investigation of simulations to replicate infrared spectra 
of CWAs and simulants. Mott considered V- and G-series compounds as well as 
simulants but all were modelled in the gas phase and show variable reproducibility of 
the P=O stretches in fluorinated derivatives (31). Cuisset modelled simulants DMMP, 
TMP and TEP at MP2/6-311++G(d,p) and DFT/B3LYP/6-311G++(3df,2p) levels of 
theory to extract infrared data and attempt to discriminate between species and 
conformers (32). Alam and Pearce (33) investigated the effects of explicit 
microsolvation of GB using DFT/B3LYP/6-311G++(2d,2p) to determine if the level of 
solvation had a  significant effect on the computed infrared spectra. Although the 
inclusion of water in the simulation improved the fit of the P=O stretch to experimental 
data little difference was seen between simulations of one, two, three or four solvent 
molecules. Zhang et al. (34) used DFT methods to model agents VX, VG, GA, GB and 
GD together with simulants DMMP and dimethyl (3,3-dichloroallyl)phosphonate 
(DDV). B3LYP/6-311+G(d,p) gave the best prediction of infrared spectra but 
underestimated frequencies associated with bonds to phosphorus. Hameka et al. (35, 36) 
applied the HF/6-31G* method to model methylphosphonates and related species but 
required further correction factors to match experimental infrared spectra. A higher 
level (MP2/aug-cc-pVTZ) study of GB, undertaken to investigate its thermal 
decomposition mechanism, gave good agreement with experimental data from 750 and 
1500 cm
-1
 but still overestimated C-H stretching modes by ca. 100 cm
-1
 (37).  
 Herein, we report on a combination of semi-empirical and DFT approaches to 
model CWAs and their simulants with the aim of generating structures that accurately 
reproduce experimentally determined infrared spectra. These models can be used to 
give insight into complexation of the different species and reasons why simulants often 
fail to bind in the same manner as the agents. To determine if the formation of 
supramolecules incorporating CWAs and simulants involved similar interactions, α-
cyclodextrin (α-CD) inclusion complexes of GB and selected simulants were modelled. 
 
Methods 
Calculations were undertaken using the Spartan ’16 Parallel Suite (38) running on a 
Mac Pro with 3.5 GHz 6-Core Intel Xenon E5 processors and two threads per core. 
CWAs and simulants were constructed using the Build option. A full conformational 
search of the CWA structure using molecular mechanics (MMFF) followed by 
geometry refinement by DFT (EDF2/6-31G then 6-311++G**). Vibrational frequencies 
were calculated after the final DFT geometry refinement. For solvated structures the 
same method was applied but with the addition of 55 water molecules to simulate a 
molar aqueous solution. Following a semi-empirical geometry refinement (PM6), all 
non-hydrogen-bonding water molecules were removed and the first DFT calculation 
(EDF2/6-31G) undertaken with the oxygen atoms of the associated water molecules 
frozen. After the second DFT step (EDF2/6-311++G**) the water molecules were 
deleted and the single point energy calculated for the CWA structure. This geometry 
was used to derive vibrational frequencies which incorporate the effects of hydrogen 
bonding to the CWA. The α-CD host was geometry optimised by semi-empirical 
methods from its X-ray coordinates (39) before refinement by HF/3-21G then 
DFT/EDF2/6-311G. 
 Results and Discussion 
Validation of Molecular Structure  
GB in the Gas and Liquid Phase  
The optimised geometry of GB was calculated at increasing levels of computational 
sophistication. The MMFF forcefield was used for the molecular mechanics simulation, 
PM6 was used for semi-empirical calculations and a range of functionals and basis sets 
were used for DFT calculations. The geometry optimised structures from each of these 
simulations were used to generate infrared spectra (see Supplementary Information, S5-
S13). Two factors were considered: was the simulated spectrum in broad agreement 
with the experimental spectra and did the peaks due to the P=O stretch and asymmetric 
P-O-R stretch correlate with the experimental values? Experimental gas phase spectra 
from Piffath (40), Sharpe (41), Heiss (42) and liquid phase Dstl data (see 
Supplementary Information, S3) were used for reference.  
From inspection of the data presented in Table 1 it is clear that peaks due to C-H 
vibrations in the region just below 3000 cm
-1
 are poorly replicated, except by MMFF, 
which is an acknowledged issue with infrared simulations (31). Consequently the 
fingerprint region is of greater analytical importance. The best results, which most 
closely matched data from Piffath (40), were obtained using the DFT/EDF2/6-
311++G** model (Figure 2). 
Gas Phase Calculations for CWAs and Simulants 
Following on from the method adopted to model GB, three other chemical warfare 
agents (GA, GD and GF) and 11 simulants (DEMP, DIMP, DMMP, DIFP, DECP, 
DECyP, TMP, TEP, TiPP, TnPP and TnBP) were modelled in the gas phase (Tables 2, 
3 and 4). Of these the calculated infrared spectra for the G-series were in good 
 agreement with experimental values. The simulants, other than DMMP and DEMP, also 
modelled well. 
 
Table 1. Calculated gas phase spectra vs experimental liquid phase spectra for GB.  
 
Hydrated GB 
The CWAs will always encounter water molecules in the natural environment, if only 
from humid air. To explicitly include the effect of water molecules on GB, simulations 
were constructed in which a single GB molecule was surrounded by 55 water 
molecules, approximating a molar solution, and geometry optimization undertaken 
using PM6 from a MMFF starting geometry. The resulting simulation was inspected 
and all water molecules not hydrogen bonded to GB were removed. Geometry 
optimization by DFT/EDF2/6-31G* followed and the output inspected again. Any water 
molecules no longer within hydrogen bonding distance were removed. The oxygen 
atoms of those remaining water molecules were frozen and optimization resumed using 
  Expt
 
(Dstl) Expt
[40]
 MMFF PM6 
EDF2/6-
311++G** 
IR (cm⁻¹)          
C-H str 2977 + 2930 2986 + 2935 2991 + 2989 2845 + 2799 3118 + 3043 
CH₃ def 1497 + 1465  1469 + 1458 1463 + 1457 1204 1489 + 1475 
P-CH₃ asym 
def 
1418 1420 1449 1336 1419 
CH₃ i-pr def 1385 + 1342 1389 + 1379 1438 + 1430 1343 + 1328 1398 + 1361  
P-CH₃ sym def 1315 1321 1416 1200 1345 
P=O str * 1278 1254 1191 1294 
P-O-i-pr 1136 + 1121 
1180 + 1145 + 
1106 
1147 + 1137 + 
1101 
1162 + 1158 
1199 + 1164 + 
1128 
P-O-C str 994 1015 1060 1038 1008 
P-CH₃ rock 936 924 + 907 898 + 883 955 940 + 924 
P-F str 874 838 930 756 809 
P-O-C bend 810 778 743  - 763 
P-C str 754 723 724  - 716 
*experimental P=O stretch obscured by a shoulder from 1300-1124 cm
-1
 
 DFT/EDF2 with either the 6-311++G** or 6-311G (2df, 2p) basis set. Following this 
final optimization step, the water molecules were removed and a single point energy 
calculation was used as the input to generate the infrared spectrum. Incorporating p-
orbital derived diffuse effects in the latter basis set appeared to give a better correlation 
with the Piffath and Sharpe spectra when the hydrated model was adopted (see Table 5 
and Supplementary Information, S10). Furthermore, the absorbance peak shifts for P-O-
R and P=O bonds were consistent with those observed for the simulant DMMP when it 
was hydrated (40). 
 
Figure 2. Simulated gas phase spectrum of GB (DFT/EDF2/6-311++G**) 
Table 2. Gas phase data for CWAs. 
CWA Structure 
IR expt
[40, 42]                          
(P=O, P-O-R) 
IR calcd
a
               
(P=O, P-O-R) 
IR calcd
[31]               
(P=O, P-O-R) 
VX 
 
1227, 1031 1239, 1073 1232, 1067 
VG 
 
1255, 1012 + 966 1253, 1053 + 966 
1259, 1063 + 
1040 
GA (tabun) 1269, 1030 1271, 1054 1267, 1054 
GB (sarin) 
 
1278, 1015 1294, 1008 1308, 1015 
GD (soman) 
 
1283, 1018 1291, 985 1304, 1025 + 987 
GF (cyclosarin) 
 
1281, 1058 + 
1032 
1299, 1038 + 998 
1308, 1048 + 
1026 
a
this work, DFT/ EDF2/6-311++G** 
  
Table 3. Gas phase data for dialkyl phosphonate and phosphate simulants 
Simulant Structure 
IR expt
[40]                          
(P=O, P-O-R) 
IR calcd
a
           
(P=O, P-O-R) 
TMP 
 
1292, 1060 1271, 1072 
TEP 1280, 1050 1260, 1052 + 957 
TiPP 1259, 980 1259, 999 
TnPP 
1268, 1044 + 
986 
1291, 1037 + 
1020 + 1000 
TnBP 
1274, 1028 + 
991 
1291, 1044 + 
1019 
a
this work, DFT/ EDF2/6-311++G** 
 
Table 4. Gas phase data for trialkyl phosphate simulants 
 
Simulant Structure 
IR expt
[40,41]                          
(P=O, P-O-R) 
IR calcd
a
           
(P=O, P-O-R) 
IR calcd
[31]                         
(P=O, P-O-R) 
DMMP 
 
  
 
1245, 1058 + 
1032 
1295, 1109 + 
1085 
1271, 1078 + 
1057 
DEMP 
  
1276, 1050 1254, 973 + 962 
1265, 1074 + 
1051 
DIMP 
  
1245, 1012 + 
963 
1249, 1015 + 983 
1242, 1005 +  
977 
DIFP 
  
1297 + 903 
1368, 1069 + 
1037 
1313, 1027 + 997 
DECP 
  
1298, 1028 1275, 1041 + 960 N/D 
DECyP 
 
1304, 1027 1289, 1052 + 957 N/D 
a
this work, DFT/ EDF2/6-311++G**, N/D not determined 
  
Table 5. Hydrated CWA data. 
 
Comparison with Other Simulations 
The most relevant literature data come from Mott (31) who calculated infrared spectra 
for 10 CWAs and five simulants by DFT using the B3LYP functional and the 6-311+G 
(d,p) basis set. All calculations were in the gas phase and correlated well with 
experiment for the P-O-R asymmetric stretch, however, the P=O stretches were shifted 
to significantly lower frequencies for GB, GD and GF. Consideration of explicit 
microsolvation in the current study (Table 5) has given more accurate results, in 
agreement with data from Alam and Pearce for GB (33), and represents a better protocol 
for the G-series of CWAs. Indeed, it may be that microsolvation is a more appropriate 
method to model other CWAs and their simulants, however, due to the extended 
computational time required, it was not considered in this study. 
Inclusion Complexes 
The validated geometry optimisation methods for gas phase CWAs and simulants were applied 
to predict the formation of host-guest complexes of α-CD with GB and a range of simulants was 
CWA Structure 
IR calcd-hyd
a
        
(P=O, P-O-R) 
IR expt
[40]                                   
(P=O, P-O-R) 
IR calcd
[31]                        
(P=O, P-O-R) 
GA (tabun) 
 
1252, 1036 1269, 1030 1267, 1054 
GB (sarin) 
 
1258, 1012 1278, 1015 1308, 1015 
GD (soman) 
 
1203, 957 1283, 1018 
1304, 1025 + 
987 
GF (cyclosarin) 
 
1290, 1013 + 
1004 
1281, 1058 + 
1032 
1308, 1048 + 
1026 
a
this work, DFT/EDF2/6-311G (2df, 2p) 
 undertaken. X-Ray structures indicate two water molecules are generally bound inside the 
cavity (39) and, when modelled, the dihydrate inclusion complex proved stable. Water 
molecules were removed from the geometry optimised α-CD and the guest molecules 
introduced at the opening of the macrocycle’s cavity. The Minimize (MMFF) routine within the 
Spartan ‘16 Build menu was used to generate an initial geometry optimization. Complexes were 
then modelled (HF/3-21G) and then refined (DFT/EDF2/6-311G*) to give a final geometry. 
Complexes were analysed to determine the orientation of the guest molecule and to what extent 
it was drawn into the host macrocycle cavity. Figures 3 to 6 and Tables 6 and 7 show how GB 
and its proposed simulants are bound by α-CD. 
 
GB Inclusion in α-CD 
While it is possible to use gas phase simulations to describe supramolecular complexes in 
organic solvents (43, 44), due to the extensive hydrogen bonding that could exist in the α-CD 
complexes an explicitly solvated approach was adopted. The simulation shows that the methyl 
group of GB is drawn into α-CD, leaving the isopropyl group outside the macrocycle’s cavity, 
and the molecule held in place through hydrogen bonding to the phosphonate oxygen by two α-
CD hydroxyl groups. These bifurcated O-H···O interactions have an average H···O distance of 
1.94 Å (Table 6) and are similar in magnitude to both modelled (45) and experimental 
intramolecular α-CD hydrogen bonds (46, 47). This motif is strengthened by two further 
intramolecular hydrogen bonds to the two hydroxyl groups involved. The model supports 
proposed mechanisms by which α-CD mimics the action of acetylcholine esterase (AChE) in 
which initial binding of the phosphate oxygen to a hydroxyl group is followed by 
phosphorylation and finally hydrolysis to liberate isopropyl methylphosphonic acid (48, 49, 50). 
Désiré and Saint-André reported a dissociation constant Kd of 40 mM at pH 8.0 for the 
complexation of racemic GB by α-CD (51) so the simulations should predict successful 
complexation between GB and α-CD. 
 
 
  
Figure 3. Top and side view of the α-CD complex with GB. 
Complex 
O-H···O 
O···O(Å) H···O(Å) O-H···O(°) 
GB to α-CD  
O–H···O 2.949 1.981 169.808 
O–H···O 2.860 1.889 169.908 
α-CD 
intramolecular 
   
O–H···O 2.759 1.792 167.615 
O–H···O 2.815 1.845 167.986 
O–H···O 2.805 1.833 169.231 
O–H···O 2.815 1.844 170.122 
O–H···O 2.874 1.915 166.302 
O–H···O 2.809 1.859 162.550 
DIMP to α-CD    
O–H···O 2.772 1.811 167.527 
O–H···O 2.799 1.827 173.852 
α-CD 
intramolecular 
   
O–H···O 2.851 1.878 170.502 
O–H···O 2.684 1.792 149.072 
O–H···O 2.776 1.829 162.613 
O–H···O 2.881 1.921 166.033 
O–H···O 2.841 1.874 168.219 
O–H···O 2.761 1.801 166.122 
DIFP to α-CD    
O–H···O 2.784 1.830 164.124 
O–H···O 2.748 1.809 159.290 
α-CD 
intramolecular 
   
O–H···O 2.798 1.819 170.427 
O–H···O 2.717 1.751 165.701 
O–H···O 2.790 1.841 162.875 
O–H···O 2.924 1.957 169.992 
O–H···O 2.853 1.889 166.502 
O–H···O 2.749 1.765 175.343 
 
Table 6. Intra- and intermolecular distances (Å) and angles (°) found in simulated α-CD 
complexes with GB, DIMP and DIFP.  
 
Simulant Inclusion in α-CD 
Phosphonates with two isopropyl substituents, DIMP and DIFP, whilst they are 
chemically similar to GB and share its bifurcated hydrogen bonding motif (Figure 4 and 
Table 6), were unable to penetrate the macrocycle due to the steric bulk of the second 
 isopropyl group which suggests that they are poor mimics for GB binding in this 
particular case study. The model is in agreement with a study by Van Hooidonk and 
Breebaart-Hansen in which DIFP was shown to interact with α-CD but 1:1 complex 
affinity was reported to be weak with Kd increasing from 78 mM at 5 °C to 460 mM at 
45 °C (52, 53). 
 
Figure 4. α-CD complexes with (from top) DIPF and DIMP. 
 
 DMMP, with a methyl and two methoxy substituents, orients its least bulky 
substituent towards the cavity in an almost identical manner to GB, and engages in 
hydrogen bonding between an α-CD hydroxyl group and the phosphonate oxygen 
(Figure 5 and Table 7). Similar binding is observed in the crystal structure of DMMP 
with a [4]resorcinarene bearing a single carboxylate group on its upper rim (54). When 
the [4]resorcinarene carboxylate points into the cavity, DMMP engages in hydrogen 
bonding and has one methoxy group descending into the macrocycle and shows 
similarities with the orientation predicted for the hydrogen bond stabilised α-CD 
complex. DMMP is a widely used simulant for GB and, despite significant structural 
 differences between the two, the modelling suggests that it is a good mimic and appears 
to bind to α-CD in a very similar fashion.  
 
Figure 5. α-CD complexes with DMMP.  
 
Figure 6. α-CD complexes with (from top) DEMP, DECP and DECyP. 
 
 The remaining three complexes with DEMP, DECP and DECyP all incorporate 
two ethoxy substituents and, as can be seen from Figure 6, one of these is drawn into the 
α-CD cavity while the phosphonate oxygen engages in hydrogen bonding with the α-
 CD hydroxyl group. In all cases the hydrogen bond lengths and angles are similar to the 
intramolecular interactions found for the cyclodextrin (Table 7), indicating that the 
simulants are able to compete efficiently with the existing hydrogen bonding network in 
order to form a stable complex.  
 
Complex 
O-H···O 
O···O(Å) H···O(Å) O-H···O(°) 
DEMP to α-CD    
O–H···O 2.749 1.836 152.165 
α-CD 
intramolecular 
   
O–H···O 2.664 1.685 172.373 
O–H···O 2.697 1.765 157.005 
O–H···O 2.648 1.694 162.079 
O–H···O 2.652 1.697 161.908 
O–H···O 2.668 1.784 148.143 
DMMP to α-CD    
O–H···O 2.764 1.793 168.466 
α-CD 
intramolecular 
   
O–H···O 2.788 1.859 157.222 
O–H···O 2.874 1.904 170.740 
O–H···O 2.817 1.901 155.134 
O–H···O 2.830 1.861 169.055 
O–H···O 2.781 1.949 141.935 
O–H···O 2.978 2.092 150.411 
DECP to α-CD    
O–H···O 2.853 1.878 164.450 
α-CD 
intramolecular 
   
O–H···O 2.966 2.017 162.502 
O–H···O 2.881 1.933 161.835 
O–H···O 2.784 1.955 141.345 
O–H···O 2.938 2.003 159.309 
O–H···O 2.785 1.856 158.302 
O–H···O 2.782 1.822 165.048 
O–H···O 2.939 1.998 160.870 
O–H···O 2.898 1.977 156.894 
DECyP to α-CD  O-H···N  
 O···N(Å) H···N(Å) O-H···N (°) 
O–H···N 2.835 1.878 165.731 
  O-H···O  
 O···O(Å) H···O(Å) O-H···O (°) 
O–H···O 2.748 1.817 158.502 
α-CD 
intramolecular 
   
O–H···O 2.918 1.940 174.441 
O–H···O 2.772 1.838 158.450 
O–H···O 2.783 1.815 167.887 
O–H···O 2.995 2.034 167.663 
O–H···O 2.804 1.831 169.974 
O–H···O 2.830 1.872 165.418 
 
Table 7. Intra- and intermolecular distances (Å) and angles (°) found in simulated α-CD 
complexes with DEMP, DMMP, DECP and DECyP. 
 
 Agents and Simulants 
Inspection of the CWAs shows that both the V- and G-series agents contain a chiral 
phosphorus centre whereas all the simulants are achiral and display pseudo-mirror plane 
symmetry. The toxicity of the G-series stems from their inactivation of AChE and it has 
been shown that for the four isomers of GD it is the chirality of the phosphorus, and not 
that of the carbon, which correlates with toxicity (55, 56). As well as a lack of chirality, 
the simulants often contain a greater number of bulky substituents than the CWA that 
they are supposed to mimic. For example, replacing the P-methyl group of GB by an 
isopropoxy group yields diisopropyl fluorophosphate (DIFP). The second isopropoxy 
group interferes with the compound’s ability to reach the active side of AChE resulting 
in much lower toxicity as borne out by crystal structures of GB and DIFP bound to Mus 
musculus AChE. These show that DIFP can only approach the phosphorylation site 
through the extensive rearrangement of a 13-residue acyl loop region to accommodate 
both isopropoxy substituents whereas GB requires no such rearrangement (57). In 
addition, DIFP has been shown to have inhibition rate constants orders of magnitude 
lower than the G-series agents GB, GD and GF which reflect the difficulty experienced 
by DIFP in binding to the active site (58).  
 A good simulant should bind to a substrate in a similar manner to a CWA while 
ensuring that other sidechains are oriented away from the binding site. Interestingly, all 
three simulants with ethoxy substituents, DEMP, DECP and DECyP, are able to thread 
one ethyl group into the hydrophobic CD cavity and engage in hydrogen bonding. 
These simulations suggest that the best mimics for GB are not those with isopropoxy 
substituents but those with ethoxy groups and an electronegative substituent. Thus 
DEMP, DECP and DECyP appear to be better mimics for GB than DIFP in this specific 
case study even though the latter has isopropoxy and fluoro substituents in common 
 with the agent. It is important to note that other factors must also be considered when 
choosing appropriate simulants for CWAs. For example, DECP hydrolyses readily (59) 
and, while it may be appropriate as a simulant for gas phase detection systems such as 
those based on surface plasmon resonance (54) or similar techniques, would be 
unsuitable if aqueous sampling was undertaken. Similarly, DMMP, despite its attractive 
lack of steric bulk, typically exhibits quite weak binding (60).  
 
Conclusions 
A relatively simple method has been developed to predict the structures of CWAs and 
simulants with infrared spectra calculated from these structures more closely matching 
experimental data than previously reported methods. α-CD inclusion complexes of GB 
and simulants were modelled as the macrocycles are known to bind CWAs (61) and 
their derivatives have used as agent decontaminants (62). Analysis of these inclusion 
complexes suggests that simulants with ethoxy substituents, DECP and DECyP, may be 
able to mimic the inclusion behaviour of GB more effectively than DIMP or DIFP with 
their two bulky isopropoxy groups. This work complements recent studies into the 
inclusion behaviour of GD and commonly used simulants within the larger hydrophobic 
cavity of β-CD where simulant complexation was shown to occur with significantly 
weaker affinity than GD complexation (63). 
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